Orbimed Advisors - NOVUS THERAPEUTICS INC ownership

NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 1 filers reported holding NOVUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of NOVUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$54,435,000
+3631.0%
3,183,3140.0%0.68%
+3157.1%
Q2 2020$1,459,000
+17.6%
3,183,3140.0%0.02%0.0%
Q1 2020$1,241,000
-32.8%
3,183,3140.0%0.02%
-19.2%
Q4 2019$1,846,000
-6.5%
3,183,3140.0%0.03%
-29.7%
Q3 2019$1,974,000
-38.6%
3,183,3140.0%0.04%
-26.0%
Q2 2019$3,215,000
-68.5%
3,183,314
+25.5%
0.05%
-68.4%
Q1 2019$10,199,000
+151.3%
2,537,1100.0%0.16%
+110.7%
Q4 2018$4,059,000
-65.7%
2,537,1100.0%0.08%
-47.6%
Q3 2018$11,848,000
-33.3%
2,537,1100.0%0.14%
-32.5%
Q2 2018$17,760,000
+38.9%
2,537,1100.0%0.21%
+33.3%
Q1 2018$12,787,000
+24.1%
2,537,1100.0%0.16%
+22.3%
Q4 2017$10,301,000
-22.1%
2,537,1100.0%0.13%
+3.2%
Q3 2017$13,218,000
-10.9%
2,537,1100.0%0.13%
-19.2%
Q2 2017$14,842,0002,537,1100.16%
Other shareholders

There were no reported owners of NOVUS THERAPEUTICS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of NOVUS THERAPEUTICS INC shareholders